✦ LIBER ✦

Use of surrogate endpoints: a practical necessity in lipid-altering and antiatherosclerosis drug development

✍ Scribed by David G Orloff

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Value, Qualification, and Regulatory

✍ Lathia, CD; Amakye, D; Dai, W; Girman, C; Madani, S; Mayne, J; MacCarthy, P; Per 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 225 KB

Development and validation of a new mode

✍ J. M. GIRAUDEL; A. DIQUELOU; P. LEES; P. L. TOUTAIN 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB